Mcnulty Korea

한국맥널티 · 222980

Consumer Staples Food & Beverage · KOSDAQ

Small-cap

Market cap US$14.5M (₩20B)

Overview

Mcnulty Korea makes and supplies coffee products, from raw unroasted beans through roasted whole-bean coffee, freeze-dried instant coffee, and ready-to-drink liquid coffee, to consumers in South Korea.

Its products span the full range from everyday instant formats to specialty and home-brewing options. Listed on KOSDAQ, South Korea's tech and small-cap exchange, the company operates a vertically integrated structure that covers importing green coffee beans all the way through to finished packaged products.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$69.8M

▲ +8.4% YoY

Operating profit · FY2025

−US$800.4K

Turned to loss

Net income · FY2025

−US$925.8K

Loss widened

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$56.8M(₩78.4B)	US$64.4M(₩88.8B)	US$69.8M(₩96.3B)
Operating profit	−US$3M(−₩4.2B)	US$414K(₩571.3M)	−US$800.4K(−₩1.1B)
Net income	−US$3.1M(−₩4.3B)	−US$254.9K(−₩351.7M)	−US$925.8K(−₩1.3B)

Revenue

FY2023US$56.8M
FY2024US$64.4M
FY2025US$69.8M

Operating profit

FY2023−US$3M
FY2024US$414K
FY2025−US$800.4K

Net income

FY2023−US$3.1M
FY2024−US$254.9K
FY2025−US$925.8K

Key ratios (FY2025)

ROE

-3.4%

Debt/Eq

123.8%

Op. margin

-1.1%

Net margin

-1.3%

Rev. YoY

▲ +8.4%

Why it matters

The company lists 맥널티제약(주) and 맥널티바이오(주) as affiliated entities operating in pharmaceuticals and health-functional foods, extending the business beyond coffee.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?